ART fees too high: HIV, Aids Stakeholders
STAKEHOLDERS in the HIV and Aids sector have complained over “deterrent” Antiretroviral Treatment (ART) user fees saying they are discouraging ...
Read moreDetailsSTAKEHOLDERS in the HIV and Aids sector have complained over “deterrent” Antiretroviral Treatment (ART) user fees saying they are discouraging ...
Read moreDetails